SPECIFIC FEATURES OF THE SPREAD OF DISEASES CAUSED BY ACINETOBACTER SPP. AT A CHILDREN'S MULTIDISCIPLINARY HOSPITAL
- Autores: MARTYNOVA A.M1, YUSHCHENKO G.V2
-
Afiliações:
- Morozov City Children's Clinical Hospital, Moscow Healthcare Department
- Russian Medical Academy of Postgraduate Education
- Edição: Nº 3 (2015)
- Páginas: 11-15
- Seção: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/278254
- ID: 278254
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
A total of 332 case histories, including 43 from the surgery units, 17 from the ophthalmology unit, 22 from the ENT unit, 29 from the intensive care unit, 28 from of the somatic units (including 22 from the pediatric units, 3 from the hematologic oncology and hematology unit, 3 from the neurology units), and 193 from the infectious disease units, in the period 2008 to 2012 were retrospectively analyzed. A total of 332 Acinetobacter spp. infection cases, including 218 carried infection cases and 114 nosocomial infection cases, were notified during 5 years. The mean in-hospital morbidity rates for Acinetobacter infection over 5 years was 0.63%. During this period, Acinetobacter lwiffii species (54%) was predominant among the isolated Acinetobacter spp. strains in carried infection cases and Acinetobacter baumannii (50%) was among nosocomial infections.
Texto integral
Sobre autores
A. MARTYNOVA
Morozov City Children's Clinical Hospital, Moscow Healthcare Department
Email: chernovaam@rambler.ru
Moscow
G. YUSHCHENKO
Russian Medical Academy of Postgraduate Education
Email: chernovaam@rambler.ru
Moscow
Bibliografia
- Мартинович А.А. Динамика антибиотикорезистентности и эпидемиология инфекций, вызванных Acinetobacter spp., в России. Клин. микробиол. антимикроб. химиотер. 2010; 12 (2): 96-99.
- Wisplinghoff H., Hippler C., Bartual S., Rodriguez-Valera F., Haefs C., Stefanik D., Seifert H. Molecular epidemiology of clinical Acinetobacter baumannii isolates from Europe and the U.S. using a new MLST scheme. 45th ICAAC. Abstract C2-1428: 126.
- Abbo A., Navon-Venezia S., Siegman-Igra Y., Carmeli Y. Impact of multi-drug resistant Acinetobacter baumannii (MDR-AB) on patients clinical outcomes. 45th ICA AC. Abstract K-1302: 336.
- Тарабукина Н.П., Неустроев М.И., Парникова С.И., Федорова М.И., Банщев А.А. Микробиологические исследования акагирского мамонта. Материалы международной научной конференции «Юкагирский мамонт: результаты первого этапа исследований». Якутск, 2004; 29.
- Репин В.Е., Пугачев В.Г., Таранов О.С., Тотменина О.Д., Беликов С.И., Андреева И.С. Биоразнообразие микроорганизмов, извлеченных из мозга юкагирского мамонта. Материалы международной научной конференции «Юкагирский мамонт: результаты первого этапа исследований». Якутск, 2004; 30.
- Горбич Ю.Л., Карпов И.А., Кречикова О.И. Инфекции, вызванные Acinetobacter baumannii: факторы риска, диагностика, лечение, подходы к профилактике. Медицинские новости 2011; 5: 31-39.
- Свистунов С.А., Кузин А.А., Суборова Т.Н., Огарков П.И., Жарков Д.А., Медведев И.Ю. Роль Acinetobacter spp. в этиологии инфекций, связанных с оказанием медицинской помощи у пациентов хирургического стационара. Медицина в Кузбассе 2013; 12 (2): 59-62.
- Dally S., Lemuth K., Kaase M., Rupp S. DNA Microarray for Genotyping Antibiotic Resistance Determinants in Acinetobacter baumannii Clinical Isolates. Antimicrob. Agents Chemother. 2013; 57(10): 4761-4768.